Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Other Operating Expenses: 2011-2025

Historic Other Operating Expenses for Aytu Biopharma (AYTU) over the last 14 years, with Jun 2025 value amounting to $32.9 million.

  • Aytu Biopharma's Other Operating Expenses fell 12.37% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 26.48%. This contributed to the annual value of $32.9 million for FY2025, which is 27.50% up from last year.
  • As of FY2025, Aytu Biopharma's Other Operating Expenses stood at $32.9 million, which was up 27.50% from $25.8 million recorded in FY2024.
  • Aytu Biopharma's 5-year Other Operating Expenses high stood at $51.0 million for FY2023, and its period low was -$110.2 million during FY2022.
  • Over the past 3 years, Aytu Biopharma's median Other Operating Expenses value was $32.9 million (recorded in 2025), while the average stood at $36.5 million.
  • Per our database at Business Quant, Aytu Biopharma's Other Operating Expenses crashed by 111.52% in 2021 and then skyrocketed by 146.27% in 2023.
  • Yearly analysis of 5 years shows Aytu Biopharma's Other Operating Expenses stood at -$74.7 million in 2021, then plummeted by 47.47% to -$110.2 million in 2022, then surged by 146.27% to $51.0 million in 2023, then tumbled by 49.45% to $25.8 million in 2024, then increased by 27.50% to $32.9 million in 2025.